Cargando…
Cardiomyocyte differentiation of mesenchymal stem cells from bone marrow: new regulators and its implications
In the past years, cardiac mortality has decreased, but cardiac diseases are still responsible for millions of deaths every year worldwide. Bone-marrow mesenchymal stem cells (BMSCs) transplantation may be a promising therapeutic strategy because of its capacity to differentiate into cardiac cells....
Autores principales: | Guo, Xiaofei, Bai, Yan, Zhang, Li, Zhang, Bo, Zagidullin, Naufal, Carvalho, Katherine, Du, Zhimin, Cai, Benzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828435/ https://www.ncbi.nlm.nih.gov/pubmed/29482607 http://dx.doi.org/10.1186/s13287-018-0773-9 |
Ejemplares similares
-
Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration
por: Gong, Rui, et al.
Publicado: (2021) -
Editorial: Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches
por: Zagidullin, Naufal, et al.
Publicado: (2021) -
Cyclin L1 controls cardiomyocyte proliferation and heart repair after injury
por: Gong, Rui, et al.
Publicado: (2023) -
Inhibition of iron overload-induced apoptosis and necrosis of bone marrow mesenchymal stem cells by melatonin
por: Yang, Fan, et al.
Publicado: (2017) -
Notch1 is associated with the differentiation of human bone marrow-derived mesenchymal stem cells to cardiomyocytes
por: Yu, Zipu, et al.
Publicado: (2016)